Banquisio, Rhianna S.

HRN: 22-75-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/17/2023
CEFUROXIME 750MG (VIAL)
03/17/2023
03/24/2023
INTRAVENOUS
300 Mg
Q8h
Burns
Waiting Final Action 
03/17/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
03/17/2023
03/24/2023
TOPICAL
1%
BID
Burns
Waiting Final Action 
03/22/2023
CLOXACILLIN 250MG/5ML, 60ML SUSPENSION (BOT)
03/22/2023
03/29/2023
ORAL
5 Ml
Q6h
Burns
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: